Biorestorative Therapies Inc. (BRTX)
NASDAQ · Healthcare
Biorestorative Therapies Inc. EBITDA 2011–2025
Biorestorative Therapies Inc. annual/quarterly ebitda history and growth rate from 2011 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Biorestorative Therapies Inc. ebitda for the quarter ending March 31, 2026 was -3.3 M, a 29.91% decrease year-over-year.
- Biorestorative Therapies Inc. ebitda for the twelve months ending March 31, 2026 was -17.9 M, a 22.56% decrease year-over-year.
- Biorestorative Therapies Inc. annual ebitda for 2025 was -15.4 M, a 35.82% increase from 2024.
- Biorestorative Therapies Inc. annual ebitda for 2024 was -11.4 M, a 24.50% decrease from 2023.
- Biorestorative Therapies Inc. annual ebitda for 2023 was -15.1 M, a 20.15% decrease from 2022.
- Biorestorative Therapies Inc. annual ebitda for 2022 was -18.9 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Biorestorative Therapies Inc. EBITDA — FAQ
Biorestorative Therapies Inc. (BRTX) ebitda over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BRTX's ebitda history?
The chart and table above show Biorestorative Therapies Inc.'s ebitda by year and by quarter, including the growth rate.